Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Indiva Ltd V.NDVA.H

Alternate Symbol(s):  NDVAF

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of edibles and extracts. Its brands include Pearls by Gron... see more

TSXV:NDVA.H - Post Discussion

Indiva Ltd > From the CEO site - FYI
View:
Post by HARJAY on Sep 20, 2023 3:10pm

From the CEO site - FYI

@anomalloy "In our estimation, it was a clear indicator that certain cash-challenged (ie WEED ) operators are taking advantage of the current exuberance to raise additional capital. And with many MSOs currently facing the same low working capital predicament, the raises are making price point sensitive investors wary on where to purchase equity. Specifically, dilution concerns tend to crop up when companies within an industry opt to raise capital by issuing new shares, whether through secondary offerings or private placements. Such dilution can be of worry for investors, especially when the capital infusion is substantial or is anticipated to be needed multiple times within a relatively short period. As a result, it exerts downward pressure on the stock prices of these companies. This apprehension can then ripple out to affect the wider industry as investors take a step back to reevaluate their positions".... https://thedalesreport.com/trends/canopy-growth-columbia-care-capital-raises-put-the-brakes-on-msos-rally/?_thumbnail_id=7496 credit @Zeusmith for the find
 
1
Comment by irinka37 on Sep 21, 2023 12:51am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities